The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma.
about
Differences in regulation of tight junctions and cell morphology between VHL mutations from disease subtypes.Meta-analysis identifies NF-κB as a therapeutic target in renal cancer.Loss of VHL confers hypoxia-inducible factor (HIF)-dependent resistance to vesicular stomatitis virus: role of HIF in antiviral response.Emetine promotes von Hippel-Lindau-independent degradation of hypoxia-inducible factor-2α in clear cell renal carcinoma.Tumor cell invasion of von Hippel Lindau renal cell carcinoma cells is mediated by membrane type-1 matrix metalloproteinase.The role of components of the chromatin modification machinery in carcinogenesis of clear cell carcinoma of the ovary (Review)Von Hippel-Lindau disease (VHL): a need for a murine model with retinal hemangioblastomaVHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling.HIFing the brakes: therapeutic opportunities for treatment of human malignancies.Tonantzitlolone cytotoxicity toward renal cancer cells is PKCθ- and HSF1-dependentCurrent understanding of the molecular mechanisms of kidney cancer: a primer for urologists.Radiolabeled antibodies in renal cell carcinoma.Targeting HIF2α translation with Tempol in VHL-deficient clear cell renal cell carcinoma.Interferon-γ-induced necrosis: an antitumor biotherapeutic perspective.Pan-PI-3 kinase inhibitor SF1126 shows antitumor and antiangiogenic activity in renal cell carcinoma.Recent Advances in the Medical Treatment of Recurrent or Metastatic Renal Cell Cancer.NF-κB inhibition by bortezomib permits IFN-γ-activated RIP1 kinase-dependent necrosis in renal cell carcinoma.Renal cell carcinoma: new insights and challenges for a clinician scientist.von Hippel-Lindau tumor suppressor gene-dependent mRNA stabilization of the survival factor parathyroid hormone-related protein in human renal cell carcinoma by the RNA-binding protein HuR.Metastatic Renal Cell Cancer-Systemic Therapy.
P2860
Q33481999-5B3A7042-DE9B-4401-B09C-569089F1EC91Q35014835-476581FA-BDCB-42AA-BA2F-4FE829579A42Q35139337-070C77F5-C5A0-43AE-88CC-06F5746DCF21Q35454927-DE940D90-B4B9-4C66-B9F2-EBF67DA14B45Q35574224-4CA60083-330B-40AF-9BBB-A0B648ECB934Q36121341-70690126-F829-468A-84A0-ADED1A0701C1Q36123826-1BF5A45C-EE61-418E-9D3E-0846D356B94AQ36127410-2D06B493-4F80-4D5F-A449-19B262F7846BQ36493913-5D954024-0D56-4489-BB7F-B2EA680AB87AQ36557478-169C0DE7-297E-45A0-8A04-3FDE387E2B01Q36710400-9B9E3B2B-35FD-458B-9845-A7AE046CB888Q37022628-28535E77-7CBC-4A75-9115-9241A16E7BF8Q37030920-21138656-7FA4-4E25-B02C-C6EB597716ECQ38097514-EE90162E-6F79-4152-A14E-CB03B2DC5A9BQ38921200-A4335ED2-C377-47D7-8965-F173F7428F73Q39044249-05B9199F-9E1F-4771-B931-EA9E1CB61021Q39154595-462EB820-9C30-454A-B4A9-598E5B773B33Q39222755-9234FB4F-1B6D-4E0D-83E2-8F7231A9FA3BQ39908665-E822A83E-1062-441B-B1AA-F00963C851FDQ52643815-514088AC-C275-4ABD-8D2D-C48BA6A1AEFA
P2860
The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The role of von Hippel-Lindau ...... in renal clear cell carcinoma.
@ast
The role of von Hippel-Lindau ...... in renal clear cell carcinoma.
@en
type
label
The role of von Hippel-Lindau ...... in renal clear cell carcinoma.
@ast
The role of von Hippel-Lindau ...... in renal clear cell carcinoma.
@en
prefLabel
The role of von Hippel-Lindau ...... in renal clear cell carcinoma.
@ast
The role of von Hippel-Lindau ...... in renal clear cell carcinoma.
@en
P2093
P2860
P1476
The role of von Hippel-Lindau ...... in renal clear cell carcinoma.
@en
P2093
Michael A S Jewett
Michael Ohh
Roxana I Sufan
P2860
P356
10.1152/AJPRENAL.00424.2003
P577
2004-07-01T00:00:00Z